Abstract
We report on two novel patients with ALG11-CDG. The phenotype was characterized by severe psychomotor disability, progressive microcephaly, sensorineural hearing loss, therapy-resistant epilepsy with burst suppression EEG, cerebral atrophy with, in one of them, neuronal heterotopia, and early lethality. Analysis of ALG11 revealed compound heterozygosity involving three novel mutations: the splice site mutation c.45-2A > T, the c.36dupG duplication, and the missense mutation c.479G > T (p.G160V) that was present in both.
| Original language | English |
|---|---|
| Pages (from-to) | 16-19 |
| Number of pages | 4 |
| Journal | Molecular Genetics and Metabolism |
| Volume | 2 |
| DOIs | |
| Publication status | Published - 2015 |
Keywords
- Journal Article
Fingerprint
Dive into the research topics of 'ALG11-CDG: Three novel mutations and further characterization of the phenotype'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver